Table 5.
Repeat UPSIT assessment (n = 38).
| Age | Sex | UPSIT score (1st) | Anosmia (n = 18); non‐anosmia (n = 20) | UPSIT score (2nd) | Anosmia (n = 24); non‐anosmia (n = 14) | Absolute differences (2nd − 1st) | Interval between 1st and 2nd, years | Interval between 1st and outcome, years | Interval between 2nd and outcome, years | Phenoconversion type | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Patient 1 | 63 | M | 28 | non‐anosmia | 15 | anosmia | −13 | 5.2 | 5.8 | 0.6 | DLB |
| Patient 2 | 77 | F | 18 | anosmia | 7 | anosmia | −11 | 2.0 | 4.0 | 2.0 | disease free |
| Patient 3 | 62 | M | 24 | non‐anosmia | 14 | anosmia | −10 | 5.1 | 11.0 | 5.9 | disease free |
| Patient 4 | 57 | M | 17 | anosmia | 10 | anosmia | −7 | 2.2 | 3.2 | 1.0 | DLB |
| Patient 5 | 62 | M | 21 | non‐anosmia | 14 | anosmia | −7 | 2.2 | 9.0 | 6.8 | disease free |
| Patient 6 | 72 | M | 13 | anosmia | 7 | anosmia | −6 | 4.3 | 10.9 | 6.6 | disease free |
| Patient 7 | 64 | F | 21 | non‐anosmia | 15 | anosmia | −6 | 2.5 | 9.0 | 6.5 | disease free |
| Patient 8 | 71 | M | 20 | non‐anosmia | 14 | anosmia | −6 | 3.1 | 8.5 | 5.4 | disease free |
| Patient 9 | 71 | F | 22 | non‐anosmia | 16 | anosmia | −6 | 1.0 | 1.2 | 0.2 | disease free |
| Patient 10 | 61 | M | 19 | non‐anosmia | 14 | anosmia | −5 | 2.7 | 10.1 | 7.4 | disease free |
| Patient 11 | 77 | M | 15 | anosmia | 11 | anosmia | −4 | 4.3 | −4.0 | −8.3 | PD* |
| Patient 12 | 69 | M | 16 | anosmia | 13 | anosmia | −3 | 2.1 | 8.8 | 6.7 | disease free |
| Patient 13 | 77 | M | 16 | anosmia | 13 | anosmia | −3 | 2.0 | 8.5 | 6.5 | disease free |
| Patient 14 | 69 | M | 21 | non‐anosmia | 18 | anosmia | −3 | 2.0 | 8.1 | 6.1 | disease free |
| Patient 15 | 63 | M | 22 | non‐anosmia | 20 | non‐anosmia | −2 | 4.9 | 6.4 | 1.6 | DLB |
| Patient 16 | 65 | M | 20 | non‐anosmia | 18 | anosmia | −2 | 2.2 | 5.6 | 3.4 | DLB |
| Patient 17 | 65 | M | 29 | non‐anosmia | 27 | non‐anosmia | −2 | 1.2 | −0.3 | −1.6 | PD** |
| Patient 18 | 61 | M | 22 | non‐anosmia | 20 | non‐anosmia | −2 | 4.1 | 9.7 | 5.6 | disease free |
| Patient 19 | 62 | M | 30 | non‐anosmia | 28 | non‐anosmia | −2 | 2.2 | 8.3 | 6.1 | disease free |
| Patient 20 | 71 | M | 18 | anosmia | 17 | anosmia | −1 | 4.0 | 7.6 | 3.5 | DLB |
| Patient 21 | 70 | M | 30 | non‐anosmia | 29 | non‐anosmia | −1 | 2.1 | 8.6 | 6.5 | MSA |
| Patient 22 | 74 | M | 19 | non‐anosmia | 18 | anosmia | −1 | 4.8 | 10.7 | 5.9 | disease free |
| Patient 23 | 71 | M | 15 | anosmia | 14 | anosmia | −1 | 2.0 | 7.9 | 5.9 | disease free |
| Patient 24 | 71 | M | 15 | anosmia | 14 | anosmia | −1 | 1.1 | 7.2 | 6.1 | disease free |
| Patient 25 | 71 | M | 23 | non‐anosmia | 23 | non‐anosmia | 0 | 2.0 | 4.8 | 2.8 | MSA |
| Patient 26 | 65 | F | 14 | anosmia | 14 | anosmia | 0 | 1.2 | 3.3 | 2.1 | disease free |
| Patient 27 | 68 | F | 16 | anosmia | 17 | anosmia | 1 | 2.1 | 5.5 | 3.4 | PD |
| Patient 28 | 71 | M | 27 | non‐anosmia | 28 | non‐anosmia | 1 | 2.2 | 6.7 | 4.5 | PD |
| Patient 29 | 51 | M | 26 | non‐anosmia | 27 | non‐anosmia | 1 | 1.1 | 7.2 | 6.1 | disease free |
| Patient 30 | 64 | M | 34 | non‐anosmia | 35 | non‐anosmia | 1 | 4.3 | 10.3 | 6.0 | disease free |
| Patient 31 | 64 | M | 18 | anosmia | 19 | non‐anosmia | 1 | 4.1 | 8.2 | 4.1 | disease free |
| Patient 32 | 75 | F | 14 | anosmia | 16 | anosmia | 2 | 2.0 | 3.0 | 1.0 | DLB |
| Patient 33 | 68 | M | 18 | anosmia | 20 | non‐anosmia | 2 | 4.6 | 9.4 | 4.8 | PD |
| Patient 34 | 61 | M | 16 | anosmia | 19 | non‐anosmia | 3 | 2.1 | 8.4 | 6.3 | disease free |
| Patient 35 | 65 | M | 21 | non‐anosmia | 25 | non‐anosmia | 4 | 1.2 | 7.2 | 6.0 | disease free |
| Patient 36 | 78 | M | 13 | anosmia | 18 | anosmia | 5 | 2.2 | 7.7 | 5.5 | disease free |
| Patient 37 | 73 | M | 13 | anosmia | 19 | anosmia | 6 | 2.0 | 7.6 | 5.7 | PD |
| Patient 38 | 56 | F | 16 | anosmia | 25 | non‐anosmia | 9 | 4.2 | 6.3 | 2.1 | PD |
| Mean | 67.2 | M:31 | 20.0 | 18.2 | −1.8 | 2.7 | 6.9 | 4.1 | |||
| SD | 6.3 | F:7 | 5.4 | 6.3 | 4.6 | 1.3 | 3.2 | 3.1 |
Anosmia: < 19; non‐anosmia: 19–40; dementia with Lewy bodies, DLB; multiple system atrophy, MSA; Parkinson's disease, PD; standard deviation, SD; the Japanese version of unified Pennsylvania smell identification test, UPSIT‐J. *, UPSIT assessment was performed after developed PD.